Zoledronic acid: a once‐yearly injection for osteoporosis

Aclasta is a once‐yearly injection of the bisphosphonate zoledronic acid that offers much improved adherence compared with oral bisphosphonates. In our New products review Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Dr Elaine Dennison comments on its place in therapy. Copyright © 2008 Wiley Interface Ltd